Pediatrix Medical Group, Inc.
NYSE:MD
10.54 (USD) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,994.64 | 1,972.021 | 1,911.191 | 1,733.951 | 3,513.542 | 3,647.123 | 3,458.312 | 3,183.159 | 2,779.996 | 2,438.913 | 2,154.012 | 1,816.612 | 1,588.248 | 1,401.559 | 1,288.264 | 1,068.277 | 917.644 | 818.554 | 693.7 | 619.629 | 551.197 | 465.481 | 354.595 | 243.075 | 227 | 185.4 | 128.9 | 80.8 | 43.9 | 32.8 |
| Cost of Revenue
| 1,573.075 | 1,504.988 | 1,397.949 | 1,284.63 | 2,621.544 | 2,657.616 | 2,458.252 | 2,149.636 | 1,851.985 | 1,632.397 | 1,443.706 | 1,202.736 | 1,037.211 | 912.431 | 835.725 | 688.212 | 567.384 | 501.553 | 27.678 | 24.254 | 18.588 | 15.791 | 0 | 26.675 | 21.1 | 14.1 | 9.8 | 6.3 | 3.5 | 2.8 |
| Gross Profit
| 421.565 | 467.033 | 513.242 | 449.321 | 891.998 | 989.507 | 1,000.06 | 1,033.523 | 928.011 | 806.516 | 710.306 | 613.876 | 551.037 | 489.128 | 452.539 | 380.065 | 350.26 | 317.001 | 666.022 | 595.375 | 532.609 | 449.69 | 354.595 | 216.4 | 205.9 | 171.3 | 119.1 | 74.5 | 40.4 | 30 |
| Gross Profit Ratio
| 0.211 | 0.237 | 0.269 | 0.259 | 0.254 | 0.271 | 0.289 | 0.325 | 0.334 | 0.331 | 0.33 | 0.338 | 0.347 | 0.349 | 0.351 | 0.356 | 0.382 | 0.387 | 0.96 | 0.961 | 0.966 | 0.966 | 1 | 0.89 | 0.907 | 0.924 | 0.924 | 0.922 | 0.92 | 0.915 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 227.542 | 231.397 | 263.357 | 248.947 | 404.643 | 432.378 | 417.105 | 372.572 | 305.915 | 247.527 | 218.209 | 193.54 | 170.356 | 154.267 | 124.965 | 124.965 | 119.766 | 109.057 | 115.304 | 79.445 | 76.537 | 0 | 274.719 | 177.718 | 148.9 | 113.7 | 81.5 | 52.7 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22.197 | 0 | 0 | 0 | 393.137 | 350.354 | 310.778 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 227.542 | 231.397 | 263.357 | 248.947 | 404.643 | 432.378 | 417.105 | 372.572 | 305.915 | 247.527 | 218.209 | 193.54 | 170.356 | 154.267 | 147.162 | 124.965 | 119.766 | 109.057 | 508.441 | 429.799 | 387.315 | 331.48 | 274.719 | 177.718 | 148.9 | 113.7 | 81.5 | 52.7 | 29.5 | 20.7 |
| Other Expenses
| 186.702 | 35.636 | 32.147 | 28.441 | 78.86 | 111.281 | 102.879 | 89.264 | 64.228 | 45.99 | 39.966 | 30.816 | 25.292 | 21.95 | 16.448 | 13.071 | 9.594 | 9.47 | 9.915 | 9.353 | 8.405 | 6.135 | 21.437 | 13.81 | 12.1 | 8.7 | 4.5 | 1.8 | 0.4 | 0.2 |
| Operating Expenses
| 263.713 | 267.033 | 295.504 | 277.388 | 483.503 | 543.659 | 519.984 | 461.836 | 370.143 | 293.517 | 258.175 | 224.356 | 215.648 | 176.217 | 163.61 | 826.248 | 129.36 | 118.527 | 518.356 | 439.152 | 395.72 | 337.615 | 296.156 | 191.528 | 161 | 122.4 | 86 | 54.5 | 29.9 | 20.9 |
| Operating Income
| 7.321 | 172.688 | 202.918 | 173.518 | 416.274 | 445.848 | 480.076 | 571.687 | 557.868 | 512.999 | 452.131 | 389.52 | 355.389 | 312.911 | 288.929 | 242.029 | 220.9 | 198.474 | 147.666 | 156.223 | 136.889 | 112.075 | 58.439 | 24.872 | 44.9 | 48.9 | 33.1 | 20 | 10.5 | 9.1 |
| Operating Income Ratio
| 0.004 | 0.088 | 0.106 | 0.1 | 0.118 | 0.122 | 0.139 | 0.18 | 0.201 | 0.21 | 0.21 | 0.214 | 0.224 | 0.223 | 0.224 | 0.227 | 0.241 | 0.242 | 0.213 | 0.252 | 0.248 | 0.241 | 0.165 | 0.102 | 0.198 | 0.264 | 0.257 | 0.248 | 0.239 | 0.277 |
| Total Other Income Expenses Net
| -164.136 | -91.318 | -67.69 | -166.37 | -1,658.254 | 11.76 | 4.905 | 5.204 | 4.971 | 4.508 | 1.696 | 1.896 | 1.495 | 1.434 | 1.682 | 2.982 | 6.855 | 3.836 | 1.177 | 0.893 | 0.482 | 0.818 | -2.229 | 0.358 | 0.3 | 0.6 | 2.1 | 2 | 0.8 | 0.2 |
| Income Before Tax
| -48.359 | 81.37 | 135.228 | 7.148 | -1,241.98 | 368.839 | 410.422 | 513.799 | 539.729 | 508.616 | 448.412 | 388.171 | 353.245 | 311.152 | 287.7 | 241.418 | 227.006 | 201.278 | 146.581 | 155.821 | 135.999 | 111.737 | 56.21 | 21.459 | 42.6 | 48.5 | 34.8 | 22 | 11.2 | 9.1 |
| Income Before Tax Ratio
| -0.024 | 0.041 | 0.071 | 0.004 | -0.353 | 0.101 | 0.119 | 0.161 | 0.194 | 0.209 | 0.208 | 0.214 | 0.222 | 0.222 | 0.223 | 0.226 | 0.247 | 0.246 | 0.211 | 0.251 | 0.247 | 0.24 | 0.159 | 0.088 | 0.188 | 0.262 | 0.27 | 0.272 | 0.255 | 0.277 |
| Income Tax Expense
| 12.049 | 18.806 | 27.241 | 16.728 | -91.886 | 100.21 | 90.05 | 189.203 | 204.038 | 191.413 | 167.895 | 147.264 | 135.248 | 108.461 | 111.896 | 94.736 | 86.987 | 76.813 | 57.544 | 57.542 | 51.671 | 42.961 | 25.782 | 10.473 | 17.6 | 19.4 | 13.9 | 8.9 | 4.5 | 3.7 |
| Net Income
| -60.408 | 66.335 | 130.964 | -9.58 | -1,150.094 | 268.629 | 320.372 | 324.914 | 336.32 | 317.281 | 280.517 | 240.907 | 217.997 | 202.691 | 175.804 | 169.201 | 142.722 | 124.465 | 89.037 | 98.279 | 84.328 | 68.776 | 30.428 | 10.986 | 25 | 29.1 | 20.9 | 13.1 | 6.7 | 5.4 |
| Net Income Ratio
| -0.03 | 0.034 | 0.069 | -0.006 | -0.327 | 0.074 | 0.093 | 0.102 | 0.121 | 0.13 | 0.13 | 0.133 | 0.137 | 0.145 | 0.136 | 0.158 | 0.156 | 0.152 | 0.128 | 0.159 | 0.153 | 0.148 | 0.086 | 0.045 | 0.11 | 0.157 | 0.162 | 0.162 | 0.153 | 0.165 |
| EPS
| -0.72 | 0.79 | 1.54 | -0.11 | -13.77 | 2.95 | 3.42 | 3.47 | 3.59 | 3.3 | 2.77 | 2.41 | 2.23 | 2.17 | 1.87 | 1.85 | 1.48 | 1.3 | 0.47 | 0.51 | 0.89 | 0.67 | 0.36 | 0.18 | 0.4 | 0.24 | 0.088 | 0.11 | 0.044 | 0.041 |
| EPS Diluted
| -0.73 | 0.79 | 1.53 | -0.11 | -13.77 | 2.93 | 3.42 | 3.47 | 3.58 | 3.18 | 2.77 | 2.41 | 2.23 | 2.13 | 1.87 | 1.8 | 1.43 | 1.26 | 0.46 | 0.48 | 0.86 | 0.65 | 0.34 | 0.17 | 0.4 | 0.23 | 0.084 | 0.11 | 0.036 | 0.031 |
| EBITDA
| 196.08 | 237.358 | 251.797 | 201.959 | 495.134 | 563.954 | 583.907 | 664.136 | 625.223 | 560.769 | 492.097 | 420.336 | 380.681 | 334.861 | 305.377 | 255.1 | 224.608 | 204.108 | 156.404 | 164.683 | 144.812 | 117.392 | 79.878 | 38.324 | 56.7 | 57 | 35.5 | 19.8 | 10.1 | 9.1 |
| EBITDA Ratio
| 0.098 | 0.12 | 0.132 | 0.116 | 0.141 | 0.155 | 0.169 | 0.209 | 0.225 | 0.23 | 0.228 | 0.231 | 0.24 | 0.239 | 0.237 | 0.239 | 0.245 | 0.249 | 0.225 | 0.266 | 0.263 | 0.252 | 0.225 | 0.158 | 0.25 | 0.307 | 0.275 | 0.245 | 0.23 | 0.277 |